FDA approves Bristol-Myers drug for new use in kidney cancer

Take a look at who the members of the FDA are -- all big industry execs. And after they leave the FDA, they go right back to their corporations. They will give approval to ANYTHING! Thus all the TV commercials we see about class action suits against various drugs that ended up causing great harm.

This is a breakthrough of cancer treatment. We need to thank Ono Pharma research team who has an original patent of Optivo.